Annual ROA
-84.53%
-29.32%-53.11%
December 31, 2023
Summary
- As of February 7, 2025, ABEO annual return on assets is -84.53%, with the most recent change of -29.32% (-53.11%) on December 31, 2023.
- During the last 3 years, ABEO annual ROA has fallen by -39.55% (-87.93%).
- ABEO annual ROA is now -122.26% below its all-time high of 379.77%, reached on December 31, 2013.
Performance
ABEO ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-72.22%
-10.14%-16.33%
September 30, 2024
Summary
- As of February 7, 2025, ABEO quarterly return on assets is -72.22%, with the most recent change of -10.14% (-16.33%) on September 30, 2024.
- Over the past year, ABEO quarterly ROA has increased by +19.24% (+21.04%).
- ABEO quarterly ROA is now -104.66% below its all-time high of 1550.71%, reached on September 30, 2013.
Performance
ABEO Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ABEO ROA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -53.1% | +21.0% |
3 y3 years | -87.9% | -87.4% |
5 y5 years | -163.4% | -50.0% |
ABEO ROA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -53.1% | at low | -38.3% | +39.1% |
5 y | 5-year | -120.4% | at low | -119.5% | +39.1% |
alltime | all time | -122.3% | +86.0% | -104.7% | +97.5% |
Abeona Therapeutics ROA History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -72.22%(+16.3%) |
Jun 2024 | - | -62.08%(-47.7%) |
Mar 2024 | - | -118.64%(+29.7%) |
Dec 2023 | -84.53%(+53.1%) | -91.46%(+21.3%) |
Sep 2023 | - | -75.41%(-2.3%) |
Jun 2023 | - | -77.21%(+47.9%) |
Mar 2023 | - | -52.22%(-25.7%) |
Dec 2022 | -55.21%(-25.0%) | -70.27%(-40.2%) |
Sep 2022 | - | -117.50%(+26.3%) |
Jun 2022 | - | -93.05%(+7.6%) |
Mar 2022 | - | -86.50%(+26.7%) |
Dec 2021 | -73.61%(+63.7%) | -68.29%(+77.2%) |
Sep 2021 | - | -38.54%(+6.1%) |
Jun 2021 | - | -36.33%(+10.4%) |
Mar 2021 | - | -32.90%(-31.8%) |
Dec 2020 | -44.98%(+17.3%) | -48.23%(-1.7%) |
Sep 2020 | - | -49.04%(-10.7%) |
Jun 2020 | - | -54.90%(-10.1%) |
Mar 2020 | - | -61.09%(+38.7%) |
Dec 2019 | -38.35%(+19.5%) | -44.04%(-8.5%) |
Sep 2019 | - | -48.13%(+4.2%) |
Jun 2019 | - | -46.17%(+20.4%) |
Mar 2019 | - | -38.35%(+15.9%) |
Dec 2018 | -32.09%(+70.2%) | -33.10%(+8.0%) |
Sep 2018 | - | -30.64%(+19.6%) |
Jun 2018 | - | -25.62%(+2.5%) |
Mar 2018 | - | -25.00%(+7.5%) |
Dec 2017 | -18.85%(-17.6%) | -23.25%(-13.3%) |
Sep 2017 | - | -26.81%(+6.8%) |
Jun 2017 | - | -25.11%(+2.8%) |
Mar 2017 | - | -24.42%(-7.0%) |
Dec 2016 | -22.89%(-23.9%) | -26.26%(+20.5%) |
Sep 2016 | - | -21.79%(-16.0%) |
Jun 2016 | - | -25.95%(-3.2%) |
Mar 2016 | - | -26.80%(+1.9%) |
Dec 2015 | -30.06%(-90.3%) | -26.29%(-57.2%) |
Sep 2015 | - | -61.41%(-32.6%) |
Jun 2015 | - | -91.12%(-80.0%) |
Mar 2015 | - | -454.75%(-38.2%) |
Dec 2014 | -311.46%(-182.0%) | -735.94%(-75.0%) |
Sep 2014 | - | -2943.03%(+94.3%) |
Jun 2014 | - | -1514.32%(+3786.9%) |
Mar 2014 | - | -38.96%(-113.2%) |
Dec 2013 | 379.77%(-199.4%) | 294.52%(-81.0%) |
Sep 2013 | - | 1550.71%(+177.4%) |
Jun 2013 | - | 558.93%(-839.8%) |
Mar 2013 | - | -75.55%(-82.2%) |
Dec 2012 | -381.94%(+847.0%) | -425.29%(-63.6%) |
Sep 2012 | - | -1168.35%(+162.6%) |
Jun 2012 | - | -444.86%(+240.5%) |
Mar 2012 | - | -130.66%(+175.7%) |
Dec 2011 | -40.33% | -47.39%(+368.7%) |
Sep 2011 | - | -10.11%(-96.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | - | -255.09%(+29.6%) |
Mar 2011 | - | -196.76%(+12.0%) |
Dec 2010 | -145.59%(-75.8%) | -175.66%(-71.3%) |
Sep 2010 | - | -611.30%(+86.0%) |
Jun 2010 | - | -328.74%(-28.2%) |
Mar 2010 | - | -458.08%(-23.7%) |
Dec 2009 | -602.71%(+27.7%) | -600.67%(+113.6%) |
Sep 2009 | - | -281.21%(+23.2%) |
Jun 2009 | - | -228.18%(+21.5%) |
Mar 2009 | - | -187.79%(-33.9%) |
Dec 2008 | -471.94%(+69.0%) | -284.22%(-38.9%) |
Sep 2008 | - | -465.34%(+0.3%) |
Jun 2008 | - | -463.85%(-6.2%) |
Mar 2008 | - | -494.76%(+25.5%) |
Dec 2007 | -279.22%(+47.9%) | -394.13%(+85.1%) |
Sep 2007 | - | -212.96%(+18.0%) |
Jun 2007 | - | -180.46%(+10.6%) |
Mar 2007 | - | -163.22%(+0.3%) |
Dec 2006 | -188.78%(+916.0%) | -162.79%(+268.7%) |
Sep 2006 | - | -44.15%(+3.9%) |
Jun 2006 | - | -42.51%(-4.0%) |
Mar 2006 | - | -44.28%(+145.3%) |
Dec 2005 | -18.58%(-79.2%) | -18.05%(-82.7%) |
Sep 2005 | - | -104.51%(+11.3%) |
Jun 2005 | - | -93.90%(+28.9%) |
Mar 2005 | - | -72.85%(+0.8%) |
Dec 2004 | -89.41%(+101.7%) | -72.24%(+5.5%) |
Sep 2004 | - | -68.45%(+6.0%) |
Jun 2004 | - | -64.55%(+43.5%) |
Mar 2004 | - | -44.98%(+0.4%) |
Dec 2003 | -44.32%(+6.2%) | -44.79%(+15.3%) |
Sep 2003 | - | -38.85%(+1.6%) |
Jun 2003 | - | -38.25%(-19.7%) |
Mar 2003 | - | -47.66%(+14.7%) |
Dec 2002 | -41.73%(+93.9%) | -41.56%(+15.5%) |
Sep 2002 | - | -35.98%(+22.3%) |
Jun 2002 | - | -29.43%(+17.4%) |
Mar 2002 | - | -25.07%(+16.1%) |
Dec 2001 | -21.52%(-30.4%) | -21.59%(+4.5%) |
Sep 2001 | - | -20.67%(+0.9%) |
Jun 2001 | - | -20.49%(-5.8%) |
Mar 2001 | - | -21.75%(-18.1%) |
Dec 2000 | -30.91%(-67.3%) | -26.56%(-13.7%) |
Sep 2000 | - | -30.79%(-30.7%) |
Jun 2000 | - | -44.43%(-23.1%) |
Mar 2000 | - | -57.80%(-44.0%) |
Dec 1999 | -94.51%(-46.5%) | -103.30%(+17.8%) |
Sep 1999 | - | -87.71%(-26.7%) |
Jun 1999 | - | -119.63%(+155.2%) |
Mar 1999 | - | -46.87% |
Dec 1998 | -176.76%(+26.9%) | - |
Dec 1997 | -139.33%(-57.1%) | - |
Dec 1996 | -324.84%(-2127.7%) | - |
Dec 1995 | 16.02% | - |
FAQ
- What is Abeona Therapeutics annual return on assets?
- What is the all time high annual ROA for Abeona Therapeutics?
- What is Abeona Therapeutics annual ROA year-on-year change?
- What is Abeona Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly ROA year-on-year change?
What is Abeona Therapeutics annual return on assets?
The current annual ROA of ABEO is -84.53%
What is the all time high annual ROA for Abeona Therapeutics?
Abeona Therapeutics all-time high annual return on assets is 379.77%
What is Abeona Therapeutics annual ROA year-on-year change?
Over the past year, ABEO annual return on assets has changed by -29.32% (-53.11%)
What is Abeona Therapeutics quarterly return on assets?
The current quarterly ROA of ABEO is -72.22%
What is the all time high quarterly ROA for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly return on assets is 1550.71%
What is Abeona Therapeutics quarterly ROA year-on-year change?
Over the past year, ABEO quarterly return on assets has changed by +19.24% (+21.04%)